Description
Treatment of osteoporosis in postmenopausal women at increased risk of fracture (see section 5.1). A reduction in the risk of vertebral fractures has been demonstrated, efficacy on femoral neck fractures has not been established. The recommended dose is one 150 mg film-coated
Additional information
| brand | Martin Dow Pharmaceuticals |
|---|
